Insider · CIK 0001614578
Brian Lian
Files at VKTX (Viking Therapeutics, Inc.). First filing Jul 3, 2025, latest Jan 5, 2026.
Brian Lian files SEC Form 4 as CEO, president and director at VKTX (Viking Therapeutics, Inc.). Since Jul 3, 2025, Brian Lian has reported 0 open-market buys worth $0 and 3 open-market sells worth $9.8M, the latest filed on Jan 5, 2026.
A track record needs three past buys with six months of prices behind them; Brian Lian has 0, so none is measured yet.
The newest scored trade: sold $7.7M of VKTX on Jan 5, 2026, filed Jan 5, 2026, scored 65 (notable). In the last 12 months: 0 buys worth $0 and 2 sells worth $9.1M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VKTX: Viking Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Viking Therapeutics, Inc. | $7.7M 233,409 shares | -9% | +61% from low-24% from high | |
| 65Notable | Viking Therapeutics, Inc. | $1.4M 38,989 shares | -2% | +75% from low-53% from high | |
| 61Notable | Viking Therapeutics, Inc. | $748k 26,889 shares | -1% | +41% from low-64% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 5, 2026 | VKTX VIKING THERAPEUTICS, INC. | 233,409 0.21% of outstanding | $7.7M | Jan 5, 2026 | $1.4M |
| Oct 28, 2025 | VKTX VIKING THERAPEUTICS, INC. | 38,989 0.03% of outstanding | $1.4M | Oct 28, 2025 | none |
| Jul 3, 2025 | VKTX VIKING THERAPEUTICS, INC. | 26,889 0.02% of outstanding | $748k | Jul 3, 2025 | none |
| Jan 6, 2025 | VKTX VIKING THERAPEUTICS, INC. | 194,490 0.17% of outstanding | $8.3M | Jan 6, 2025 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | AGrant or award Common Stock, par value $0.00001 per share | +78,400 | $0.00 | $0 | 2,508,620 | Jan 5, 2026 |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | AGrant or award Common Stock, par value $0.00001 per share | +224,080 | $0.00 | $0 | 2,732,700 | Jan 5, 2026 |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share | -132,454 | $32.29 | $4.3M | 2,600,246 | Jan 5, 2026 |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share | -53,279 | $33.38 | $1.8M | 2,546,967 | Jan 5, 2026 |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share | -41,276 | $34.22 | $1.4M | 2,505,691 | Jan 5, 2026 |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share | -6,400 | $35.07 | $224k | 2,499,291 | Jan 5, 2026 |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +176,300 | $0.00 | $0 | 176,300 | Jan 5, 2026 |
| Oct 27, 2025 | VKTX Viking Therapeutics, Inc. | AGrant or award Common Stock, par value $0.00001 per share | +70,084 | $0.00 | $0 | 2,458,098 | Oct 28, 2025 |
| Oct 28, 2025 | VKTX Viking Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share | -38,989 | $35.01 | $1.4M | 2,419,109 | Oct 28, 2025 |
| Jul 2, 2025 | VKTX Viking Therapeutics, Inc. | AGrant or award Common Stock, par value $0.00001 per share | +48,333 | $0.00 | $0 | 2,414,903 | Jul 3, 2025 |
| Jul 3, 2025 | VKTX Viking Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share | -26,889 | $27.80 | $748k | 2,388,014 | Jul 3, 2025 |
Questions about Brian Lian
Answered from the filings on this page, as of the latest one.
Is Brian Lian buying or selling?
In the last 12 months Brian Lian reported 0 open-market buys worth $0 and 2 open-market sells worth $9.1M on SEC Form 4; the latest was sold $7.7M of VKTX on Jan 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Brian Lian's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Lian has 0.
Where does Brian Lian file Form 4?
Brian Lian has filed Form 4 at VKTX (Viking Therapeutics, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.